Mumbai, India

Dhananjay Pramod Tattu

This inventor holds 1 USPTO granted patent. Top assignee: Unichem Laboratories Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dhananjay Pramod Tattu. Retrieved from https://idiyas.com/inventor/dhananjay-pramod-tattu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dhananjay Pramod Tattu: Innovator in Pharmaceutical Composition

Introduction

Dhananjay Pramod Tattu is a notable inventor based in Mumbai, Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable and bioequivalent compositions of apixaban.

Latest Patents

Dhananjay holds a patent for a pharmaceutical composition of apixaban. This patent describes a stable, reproducible formulation that includes apixaban with a D-particle size of more than 100 microns, preferably between 300 and 1000 microns, and more specifically between 350 and 800 microns. The composition also contains one or more pharmaceutically acceptable excipients. Additionally, the patent outlines a process for preparing this pharmaceutical composition through wet granulation.

Career Highlights

Dhananjay Pramod Tattu is currently associated with Unichem Laboratories Limited, where he applies his expertise in pharmaceutical innovations. His work focuses on enhancing the efficacy and stability of pharmaceutical products.

Collaborations

Dhananjay has collaborated with notable colleagues, including Dhananjay Govind Sathe and Srikant V Pimple, contributing to advancements in their respective fields.

Conclusion

Dhananjay Pramod Tattu's innovative work in pharmaceutical compositions exemplifies the impact of dedicated inventors in the healthcare industry. His contributions continue to influence the development of effective medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…